Identification of Key mRNAs and Pathways in Colorectal Cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.21387
   PubMed Web of Science ®Google Scholar
• Falzone L, Salomone S, Libra M. Evolution of cancer pharmacological treatments at the turn of the third millennium. Front Pharmacol. 2018;9:1300. doi:10.3389/fphar.2018.01300
   PubMed Web of Science ®Google Scholar
• Markowitz SD, Bertagnolli MM. Molecular origins of cancer: molecular basis of colorectal cancer. N Engl J Med. 2009;361(25):2449–2460. doi:10.1056/NEJMra0804588
   PubMed Web of Science ®Google Scholar
• Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst. 2012;104(11):815–840. doi:10.1093/jnci/djs207
   PubMed Web of Science ®Google Scholar
• Xu P, Zhu Y, Sun B, Xiao Z. Colorectal cancer characterization and therapeutic target prediction based on microRNA expression profile. Sci Rep. 2016;6:20616. doi:10.1038/srep20616
   PubMed Web of Science ®Google Scholar
• Ågesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, Lind GE, Nesland JM, Bakka A, Mala T, Hauss HJ, et al. CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer. Genes Immun. 2011;12(8):653–662. doi:10.1038/gene.2011.43
   PubMed Web of Science ®Google Scholar
• Lech G, Słotwiński R, Słodkowski M, Krasnodębski IW. Colorectal cancer tumour markers and biomarkers: recent therapeutic advances. World J Gastroenterol. 2016;22(5):1745–1755. doi:10.3748/wjg.v22.i5.1745
   PubMed Web of Science ®Google Scholar
• Gröne J, Lenze D, Jurinovic V, Hummel M, Seidel H, Leder G, Beckmann G, Sommer A, Grützmann R, Pilarsky C, et al. Molecular profiles and clinical outcome of stage UICC II colon cancer patients. Int J Colorect Dis. 2011;26(7):847–858. doi:10.1007/s00384-011-1176-x
   PubMed Web of Science ®Google Scholar
• Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi M-C, Schiappa R, Guenot D, Ayadi M, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453. doi:10.1371/journal.pmed.1001453
   PubMed Web of Science ®Google Scholar
• Deyati A, Bagewadi S, Senger P, Hofmann-Apitius M, Novac N. Systems approach for the selection of micro-RNAs as therapeutic biomarkers of anti-EGFR monoclonal antibody treatment in colorectal cancer. Sci Rep. 2015;5:8013doi:10.1038/srep08013
   PubMed Web of Science ®Google Scholar
• Sun Z, Liu J, Chen C, Zhou Q, Yang S, Wang G, Song J, Li Z, Zhang Z, Xu J, et al. The biological effect and clinical application of long noncoding RNAs in colorectal cancer. Cell Physiol Biochem. 2018;46(2):431–441. doi:10.1159/000488610
   PubMedGoogle Scholar
• Snipstad K, Fenton CG, Kjaeve J, Cui G, Anderssen E, Paulssen RH. New specific molecular targets for radio-chemotherapy of rectal cancer. Mol Oncol. 2010;4(1):52–64. doi:10.1016/j.molonc.2009.11.002
   PubMed Web of Science ®Google Scholar
• Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, Mesteri I, Grunt TW, Zeillinger R, Pils D, et al. Correlation of circular RNA abundance with proliferation-exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057. doi:10.1038/srep08057
   PubMed Web of Science ®Google Scholar
• Cheng X, Hu M, Chen C, Hou D. Computational analysis of mRNA expression profiles identifies a novel triple-biomarker model as prognostic predictor of stage II and III colorectal adenocarcinoma patients. Cancer Manag Res. 2018;10:2945–2952. doi:10.2147/CMAR.S170502
   PubMed Web of Science ®Google Scholar
• Goossens-Beumer IJ, Derr RS, Buermans HPJ, Goeman JJ, Böhringer S, Morreau H, Nitsche U, Janssen K-P, van de Velde CJH, Kuppen PJK, et al. MicroRNA classifier and nomogram for metastasis prediction in colon cancer. Cancer Epidemiol Biomark Prev. 2015;24(1):187–197. doi:10.1158/1055-9965.EPI-14-0544-T
   PubMed Web of Science ®Google Scholar
• Ogata-Kawata H, Izumiya M, Kurioka D, Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H, et al. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One. 2014;9(4):e92921. doi:10.1371/journal.pone.0092921
   PubMed Web of Science ®Google Scholar
• Sun Y, Shen S, Tang H, Xiang J, Peng Y, Tang A, Li N, Zhou W, Wang Z, Zhang D, et al. miR-429 identified by dynamic transcriptome analysis is a new candidate biomarker for colorectal cancer prognosis. OMICS. 2014;18(1):54–64. doi:10.1089/omi.2012.0132
   PubMed Web of Science ®Google Scholar
• Guo S, Zhang J, Wang B, Zhang B, Wang X, Huang L, Liu H, Jia B. A 5-serum miRNA panel for the early detection of colorectal cancer. Onco Targets Ther. 2018;11:2603–2614. doi:10.2147/OTT.S153535
   PubMed Web of Science ®Google Scholar
• Falzone L, Scola L, Zanghì A, Biondi A, Di Cataldo A, Libra M, Candido S. Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development. Aging (Albany NY)). 2018;10(5):1000–1014. doi:10.18632/aging.101444
   PubMedGoogle Scholar
• Falzone L, Candido S, Salemi R, Basile MS, Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M, Libra M, et al. Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer. Oncotarget. 2016;7(45):72758–72766. doi:10.18632/oncotarget.11805
   PubMedGoogle Scholar
• Hafsi S, Candido S, Maestro R, Falzone L, Soua Z, Bonavida B, Spandidos DA, Libra M. Correlation between the overexpression of Yin Yang 1 and the expression levels of miRNAs in Burkitt's lymphoma: a computational study. Oncol Lett. 2016;11(2):1021–1025. doi:10.3892/ol.2015.4031
   PubMed Web of Science ®Google Scholar
• Zhang T, Guo J, Gu J, Wang Z, Wang G, Li H, Wang J. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments. Oncol Rep. 2019;41(1):279–291. doi:10.3892/or.2018.6840
   PubMed Web of Science ®Google Scholar
• Liang B, Li C, Zhao J. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Med Oncol. 2016;33(10):111. doi:10.1007/s12032-016-0829-6
   PubMed Web of Science ®Google Scholar
• Koduru SV, Tiwari AK, Hazard SW, Mahajan M, Ravnic DJ. Exploration of small RNA-seq data for small non-coding RNAs in human colorectal cancer. J Genom. 2017;5:16–31. doi:10.7150/jgen.18856
   PubMedGoogle Scholar
• Falzone L, Romano GL, Salemi R, Bucolo C, Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M, Candido S, et al. Prognostic significance of deregulated microRNAs in uveal melanomas. Mol Med Rep. 2019;19(4):2599–2610. doi:10.3892/mmr.2019.9949
   PubMed Web of Science ®Google Scholar
• Su Y, Zhang M, Zhang L, Chen S, Zhang D, Zhang X. Construction of an miRNA-mRNA regulatory network in colorectal cancer with bioinformatics methods. Anticancer Drugs. 2019;30(6):588–595. doi:10.1097/CAD.0000000000000745
   PubMed Web of Science ®Google Scholar
• Li R, Grimm SA, Mav D, Gu H, Djukovic D, Shah R, Merrick BA, Raftery D, Wade PA. Transcriptome and DNA methylome analysis in a mouse model of diet-induced obesity predicts increased risk of colorectal cancer. Cell Rep. 2018;22(3):624–637. doi:10.1016/j.celrep.2017.12.071
   PubMed Web of Science ®Google Scholar
• Zhou X-G, Huang X-L, Liang S-Y, Tang S-M, Wu S-K, Huang T-T, Mo Z-N, Wang Q-Y. Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis. Onco Targets Ther. 2018;11:2815–2830. doi:10.2147/OTT.S163891
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, Uetake H, Tanaka H, Sugihara K. Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res. 2011;17(8):2444–2450. doi:10.1158/1078-0432.CCR-10-2884
   PubMed Web of Science ®Google Scholar
• Law CW, Alhamdoosh M, Su S, Smyth GK, Ritchie ME. RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR. F1000Res. 2016;5:1408. doi:10.12688/f1000research.9005.2
   Google Scholar
• Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Diboun I, Wernisch L, Orengo CA, Koltzenburg M. Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma. BMC Genomics. 2006;7(1):252. doi:10.1186/1471-2164-7-252
   PubMed Web of Science ®Google Scholar
• Cao C, Wang W, Ma C, Jiang P. Computational analysis identifies invasion-associated genes in pituitary adenomas. Mol Med Rep. 2015;12(2):1977–1982. doi:10.3892/mmr.2015.3564
   PubMed Web of Science ®Google Scholar
• Luo W, Brouwer C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 2013;29(14):1830–1831. doi:10.1093/bioinformatics/btt285
   PubMed Web of Science ®Google Scholar
• Del Carratore F, Jankevics A, Eisinga R, Heskes T, Hong F, Breitling R. RankProd 2.0: a refactored bioconductor package for detecting differentially expressed features in molecular profiling datasets. Bioinformatics. 2017;33(17):2774–2775. doi:10.1093/bioinformatics/btx292
   PubMed Web of Science ®Google Scholar
• Moosavi A, Motevalizadeh Ardekani A. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016;20(5):246–258. doi:10.22045/ibj.2016.01
   PubMedGoogle Scholar
• Perez R, Wu N, Klipfel AA, Beart RW Jr. A better cell cycle target for gene therapy of colorectal cancer: cyclin G. J Gastrointest Surg. 2003;7(7):884–889. doi:10.1007/s11605-003-0034-8
   PubMed Web of Science ®Google Scholar
• Tominaga O, Nita ME, Nagawa H, Fujii S, Tsuruo T, Muto T. Expressions of cell cycle regulators in human colorectal cancer cell lines. Jpn J Cancer Res. 1997;88(9):855–860. doi:10.1111/j.1349-7006.1997.tb00461.x
   PubMedGoogle Scholar